Form D · Biotechnology
PROTOX THERAPEUTICS INC
Vancouver, A1 · CIK 0001384825
Offering snapshot reported Oct 12, 2010 · SEC filing
- Reported sold
- Yet to sell Offering amount: $59.4M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 12, 2010 | Initial | Yet to sell | No comparison | 2 | SEC filing |
| Apr 15, 2010 | Initial | $226,398 | No comparison | 3 | SEC filing |
| Dec 13, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-148815
Aggregate offering includes amount that may be received by Issuer upon exercise of warrants. Each whole warrant may be exercised for one additional common share at an exercise price of CDN$0.50 per share for a period of 5 years from Closing.
Unit offering: Unit = 1 common share and a 0.6 common share warrant.
Source: Form D, filed Oct 12, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Samuel Denmeade | Executive |
| Avtar Dhillon | Director |
| Tom D'orazio | Executive |
| Jack Geltosky | Director |
| Alexander Giaquinto | Director |
| Jim Heppell | Director |
| Frank Holler | Director |
| Fahar Merchant | Director, Executive |
| Nina Merchant | Executive |
| James Miller | Director |
| John Parkinson | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
885 West Georgia Street Suite 1210 Box 1014 Hsbc Building
Vancouver, A1, V6C 3E8
Vancouver, A1, V6C 3E8